- ICH GCP
- EU Kliniske forsøgsregister
Seneste forsøg
EudraCT Number: 2006-004510-41 | Sponsor Protocol Number: GEICAM/2006-03 | Start Date: 2006-12-01 | |||||||||||
Sponsor Name: GEICAM (GRUPO ESPAÑOL DE INVESTIGACION EN CANCER DE MAMA) | |||||||||||||
Full Title: ESTUDIO MULTICÉNTRICO FASE II DE DISTRIBUCIÓN ALEATORIA, PARA EVALUAR LA EFICACIA DE TRATAMIENTO NEOADYUVANTE SELECTIVO SEGÚN SUBTIPO INMUNOHISTOQUÍMICO EN CÁNCER DE MAMA HER2 NEGATIVO | |||||||||||||
Medical condition: Pacientes con cáncer de mama primario operable o localmente avanzado que presenten tumores mayores o iguales a 2 cm de diámetro o menores de 2 cm y afectación axilar. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-003302-25 | Sponsor Protocol Number: PRG-OXYCODONE-06/01 | Start Date: 2006-11-30 | ||||||
Sponsor Name: Barts and The London NHS Trust | ||||||||
Full Title: A prospective, randomised, double-blind, placebo-controlled trial to assess the respiratory effects of oxycodone versus morphine in anaesthetised patients | ||||||||
Medical condition: Patients scheduled to undergo surgery of more than 30 minutes duration under general anaesthesia will be recruited. We are not investigating a medical disease. | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-001062-17 | Sponsor Protocol Number: ASF-1096-201/250912BS | Start Date: 2006-11-30 | |||||||||||
Sponsor Name: Astion Danmark A/S | |||||||||||||
Full Title: Efficacy and safety of ASF-1096 cream 0.5% in the treatment of patients with newly developed discoid lupus erythymatosus (DLE) lesions. A multi centre clinical phase 2, placebo controlled and doubl... | |||||||||||||
Medical condition: Male or female patients with a clinical diagnosis of either Discoid Lupus Erythmatosus or Systemic Lupus Erythmatosus and at least one newly developed, sharply demarcated DLE lesion. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) SE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001254-27 | Sponsor Protocol Number: P051205 | Start Date: 2006-11-30 | |||||||||||
Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus | |||||||||||||
Medical condition: Patients atteints de mucoviscidose, chez lesquels un diagnostic de diabète a été fait par hyperglycémie provoquée orale (HGPO) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001672-39 | Sponsor Protocol Number: CARDIOCC2004 | Start Date: 2006-11-30 | ||||||
Sponsor Name: Dr Moya Mur | ||||||||
Full Title: EFECTO PROTECTOR DE LA ATORVASTATINA SOBRE LA FUNCION MICROVASCULAR CORONARIA Y FUNCION COGNITIVA CEREBRAL EN PACIENTES SOMETIDOS A REVASCULARIZACION CORONARIA | ||||||||
Medical condition: CARDIOPATIA ISQUEMICA | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: ES (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002165-39 | Sponsor Protocol Number: P04887 | Start Date: 2006-11-30 | ||||||
Sponsor Name: Schering Plough Research Institute, a division of Schering Corporation | ||||||||
Full Title: Study of the Efficacy and Safety of SCH486757 in Subjects With Chronic Idiopathic Cough | ||||||||
Medical condition: Chronic Idiopathic Cough | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-002324-41 | Sponsor Protocol Number: PH2/051 | Start Date: 2006-11-30 | |||||||||||
Sponsor Name: Cancer Research UK | |||||||||||||
Full Title: A Cancer Research UK Randomised Multicentre Phase II Trial of the DNA-hypomethylating Agent, 5-Aza-2'-deoxycytidine(Decitabine) given intravenously in Combination with Carboplatin, versus Carboplat... | |||||||||||||
Medical condition: Progressive, advanced ovarian cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003142-42 | Sponsor Protocol Number: SC12267-3-2005 | Start Date: 2006-11-30 | |||||||||||
Sponsor Name: 4SC AG | |||||||||||||
Full Title: A Randomized, Double Blind, Placebo-controlled, Proof of Concept Study to evaluate Efficacy, Safety and Pharmacokinetics of two Different Doses of SC12267 (20mg, 35 mg) in Patients with Rheumatoid ... | |||||||||||||
Medical condition: Active Rheumatoid Arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002757-72 | Sponsor Protocol Number: NEOSH101-CLIN-AGA003 | Start Date: 2006-11-30 | |||||||||||
Sponsor Name: Neosil Inc. | |||||||||||||
Full Title: A Phase 2 Multicenter, Randomized, Placebo- and Comparator Controlled, Double-Blind Parallel Group Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alo... | |||||||||||||
Medical condition: The study will be performed in male subjects with androgenetic alopecia, Norwood -Hamilton grades III - IV. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004977-91 | Sponsor Protocol Number: ANA06104 | Start Date: 2006-11-30 | ||||||
Sponsor Name: Universitätsklinikum Mannheim, Klinik für Anästhesiologie | ||||||||
Full Title: Inhalative Sedierung mit Sevofluran im Vergleich zu Propofol bei beatmeten, postoperativen Intensivpatienten – Einfluss auf Extubationszeiten und Aufwachverhalten, Nieren- und Leberfunktion, Hämody... | ||||||||
Medical condition: Der Einsatz von Sevofluran im Vergleich zur konventionellen Sedierung mit Propofol soll in Bezug auf Sedierungsgrad unter Beatmung, Extubationszeit und Aufwachverhalten, Hämodynamik, Kardioprotekti... | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: (No results available) |